TherapeuticsMD Stock Price (NASDAQ:TXMD)

Add to My Stocks
$6.22 $0.1 (1.63%) TXMD stock closing price Sep 19, 2018 (Closing)
Prev Close* : $6.12
Market Cap:
$1.42B
Day Low: $6.16
52 Week Low: $4.34
Open: $6.16
Volume: -
Day High: $6.3
52 Week High: $7.66
Dividend:
0.00

Latest Stock Market News

Latest Articles

TherapeuticsMD News - From Partners

TXMD Stockcharts

View TXMD PE ratio, PS ratio stocks charts and compare with peers.
TXMD Chart
Note: Compare TherapeuticsMD stock price history with the index and industry peers.

TherapeuticsMD Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
83.85
PB ratio (
price to book ratio
)
12.08

TherapeuticsMD Returns

ROE
(return on equity)
-84%

TherapeuticsMD Financial Ratios

Asset Turnover
0.1
Receivables Turnover
3.52
Debt to Equity
0.94
Dividend Yield
0%

TXMD Industry Peers

Company Price Change (%)
Theravance Biopharma (TBPH)27.50.49 (1.81%)
Tricida Inc (TCDA)35.60.06 (0.17%)
Pfizer (PFE)43.260.25 (0.57%)
Novo Nordisk (NVO)470.43 (0.91%)
Juniper Pharma (JNP)11.50 (0%)
Palatin Technologies (PTN)1.030.01 (0.98%)
Abbvie (ABBV)91.021.59 (1.72%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

TherapeuticsMD Inc Stock News - Partner Headlines

TherapeuticsMD Financial Statements

income statement20172016201520142013
Net Sales or Revenues16.77M19.35M20.14M15.02M8.77M
Net Income-76.92M-89.87M-85.07M-54.21M-28.41M
Total Operating Expense91.55M105.28M100.76M65.33M32.56M
View TherapeuticsMD income statement
balance sheet20172016201520142013
Total Assets143.22M142.47M73.72M59.07M62.01M
Total Liabilities13.32M14.98M10.66M10.69M7.31M
Shareholders Equity129.9M127.48M63.06M48.38M54.69M
View TherapeuticsMD balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-6.33M--1.24M3.41M1.2M
Net Cash from (used by) Operating Activities-76.15M-69.14M-79.04M-45.52M-20.76M
Increase (Decrease) in Prop Plant And Equipment-0.06M-0.39M-0.16M-0.03M-0.04M
View TherapeuticsMD cash flow statement

TherapeuticsMD Stock Message Board

As of last trading day, TherapeuticsMD stock price was $6.22. Looking at TherapeuticsMD market capitalization, which currently stands at $1.42B, we can say that TXMD stock is a Small Cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing TherapeuticsMD stock analysis.

The terms stocks and shares mean the same thing. For Ex: TherapeuticsMD stock price and TherapeuticsMD share price mean the same thing. The volume of shares traded stood at 1,415,958 on the last trading day, as is evident from TherapeuticsMD stock chart, and TXMD stock quote data. TherapeuticsMD paid 0.00 stock dividends to its shareholders during last quarter. One can observe stock price trends and check for volatility by checking TherapeuticsMD stock price history.